The Breast Cancer Society of Canada is committed to progressing breast cancer research across Canada. From the beginning, we have focused our efforts on seed funding for translational research.
The Breast Cancer Society of Canada makes significant contributions to innovative research projects needing the upfront capital necessary to gather preliminary findings. These findings are then used to apply for federal research grants.
These projects give the latest ideas a chance to be fully examined, supporting a consistent push by Canadian researchers to eradicate breast cancer.
The Breast Cancer Society of Canada has donated more than $2.89 million to London Health Science Foundation’s Translational Breast Cancer Research Unit. They dedicated $430,000 from this donation to seed funding, enabling the preliminary findings to secure more than $4.5 million in external grants.
The Breast Cancer Society of Canada dedicates a large portion of their research funding to translational research.
Translational research is the collaborative process in which information acquired through research is used to develop new medical treatments and the implementation of those medical treatments into clinical practice.